Streetbeat News

Earnings

MTEM

Molecular Templates (NASDAQ:MTEM) reported Q2 earnings with losses of $(0.19) per share, a 55.81% improvement YoY. Sales also increased by 50.03% to $6.63 million compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:21 pm

APVO

Aptevo Therapeutics reported Q2 losses of $(1.23) per share, missing the analyst consensus estimate of $(1.12) by 9.82 percent. However, this is a 32.42 percent increase over losses of $(1.82) per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:20 pm

RL

Ralph Lauren reported Q1 earnings of $2.34 per share, beating the analyst consensus estimate of $2.13 by 9.86%. This is a 24.47% increase from the same period last year. The company also reported quarterly sales of $1.50 billion, beating the analyst consensus estimate of $1.48 billion by 1.15%. This is a 0.43% increase from the same period last year.

Portfolio Pulse from Happy Mohamed

August 10, 2023 | 12:19 pm

WWW

Wolverine World Wide, Inc. (NYSE:WWW) reported Q2 revenues of $589.10 million, beating the analyst consensus but declining 17.4% YoY. The company's international business and lower margins impacted revenue growth. The company also appointed a new CEO, Christopher E. Hufnagel, and slashed its FY23 revenue and EPS outlook. WWW shares are trading lower by 20.68% premarket.

Portfolio Pulse from Nabaparna Bhattacharya

August 10, 2023 | 12:19 pm

PLUG

Plug Power reported mixed Q2 financial results, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:18 pm

MGNI

Magnite, Inc. (MGNI) shares are trading lower following the release of the company's Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:18 pm

ORGN

Origin Materials reported mixed Q2 financial results, leading to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:18 pm

PHAT

Phathom Pharmaceuticals reported Q2 losses of $(0.84) per share, beating the analyst consensus estimate of $(1.00) by 16 percent. This is a 36.84 percent increase over losses from the same period last year. The company's cash balance of $248.8M is expected to provide a cash runway into 2025.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:18 pm

ORGO

Organogenesis has reported its Q2 financial results and has withdrawn its FY23 guidance, leading to a decrease in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:17 pm

SONO

Sonos reported better-than-expected Q3 financial results, leading to a rise in its share price.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:17 pm